Chaoju Eye Care Holdings Limited (HKG:2219)
Hong Kong · Delayed Price · Currency is HKD 2.460
-0.010 (-0.40%)
Sep 2, 2026, 4:08 PM HKT
Chaoju Eye Care Holdings Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,373 | 1,360 | 1,405 | 1,370 | 990.04 | 997.79 | |
Revenue Growth | 0.25% | -3.21% | 2.63% | 38.33% | -0.78% | 25.62% |
Cost of Revenue | 809.33 | 786.46 | 794.15 | 748.37 | 555.35 | 549.11 |
Gross Profit | 563.47 | 573.9 | 611.3 | 621.13 | 434.7 | 448.67 |
Selling, General & Admin | 342.68 | 329.6 | 362.06 | 327.45 | 223.32 | 201.93 |
Operating Expenses | 344.93 | 331.84 | 364.21 | 331.57 | 222.7 | 208.5 |
Operating Income | 218.55 | 242.06 | 247.09 | 289.56 | 212 | 240.17 |
Interest Expense | -11.37 | -12.22 | -10.65 | -12.22 | -11.9 | -10.54 |
Interest & Investment Income | 33.45 | 33.45 | 39.58 | 41.31 | 22.97 | 8.33 |
Earnings From Equity Investments | -0.07 | -0.01 | - | - | - | - |
Currency Exchange Gain (Loss) | 0.7 | 0.7 | - | - | - | 2.2 |
Other Non Operating Income (Expenses) | 8.98 | 14.16 | 3.26 | -33.01 | -4.53 | -7.11 |
EBT Excluding Unusual Items | 250.23 | 278.13 | 279.28 | 285.64 | 218.54 | 233.04 |
Impairment of Goodwill | -37.59 | -37.59 | -20.39 | -13.83 | - | - |
Gain (Loss) on Sale of Investments | 19.94 | 19.94 | 3.83 | 28.3 | 20.19 | 0.04 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.4 | - |
Asset Writedown | -3.91 | -4.38 | - | -0.87 | - | - |
Other Unusual Items | - | - | - | - | - | -22.5 |
Pretax Income | 228.67 | 256.1 | 262.72 | 299.24 | 239.14 | 210.58 |
Income Tax Expense | 69.06 | 78.69 | 76.51 | 78.51 | 55.94 | 52.94 |
Earnings From Continuing Operations | 159.61 | 177.41 | 186.21 | 220.74 | 183.2 | 157.64 |
Minority Interest in Earnings | 4.92 | 6.04 | 8.87 | 8.18 | 4.56 | 4.11 |
Net Income | 164.52 | 183.45 | 195.08 | 228.91 | 187.75 | 161.75 |
Net Income to Common | 164.52 | 183.45 | 195.08 | 228.91 | 187.75 | 161.75 |
Net Income Growth | -4.50% | -5.96% | -14.78% | 21.92% | 16.08% | 30.30% |
Shares Outstanding (Basic) | 677 | 694 | 689 | 696 | 706 | 625 |
Shares Outstanding (Diluted) | 680 | 697 | 691 | 697 | 706 | 625 |
Shares Change | -1.93% | 0.78% | -0.77% | -1.37% | 13.12% | 13.55% |
EPS (Basic) | 0.24 | 0.26 | 0.28 | 0.33 | 0.27 | 0.26 |
EPS (Diluted) | 0.24 | 0.26 | 0.28 | 0.33 | 0.27 | 0.26 |
EPS Growth | -0.76% | -7.14% | -14.92% | 23.82% | 2.62% | 14.75% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 148.65 | 117.53 | 289.89 | 292.56 | 152.33 | 191.67 |
Free Cash Flow Per Share | 0.22 | 0.17 | 0.42 | 0.42 | 0.22 | 0.31 |
Dividend Per Share | 0.218 | 0.218 | 0.235 | 0.200 | 0.154 | 0.085 |
Dividend Growth | 92.20% | -7.32% | 17.21% | 30.37% | 80.93% | - |
Gross Margin | 41.05% | 42.19% | 43.49% | 45.36% | 43.91% | 44.97% |
Operating Margin | 15.92% | 17.79% | 17.58% | 21.14% | 21.41% | 24.07% |
Profit Margin | 11.98% | 13.48% | 13.88% | 16.71% | 18.96% | 16.21% |
Free Cash Flow Margin | 10.83% | 8.64% | 20.63% | 21.36% | 15.39% | 19.21% |
EBITDA | 308.98 | 331.03 | 332.97 | 361.99 | 267.87 | 286.8 |
EBITDA Margin | 22.51% | 24.33% | 23.69% | 26.43% | 27.06% | 28.74% |
D&A For EBITDA | 90.43 | 88.97 | 85.89 | 72.43 | 55.87 | 46.63 |
EBIT | 218.55 | 242.06 | 247.09 | 289.56 | 212 | 240.17 |
EBIT Margin | 15.92% | 17.79% | 17.58% | 21.14% | 21.41% | 24.07% |
Effective Tax Rate | 30.20% | 30.73% | 29.12% | 26.24% | 23.39% | 25.14% |